SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company with a market capitalization of $4.5 million, announced nonclinical results for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback